| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 34.655 | 42.327 | 53.793 | 67.471 | 73.670 | 99.159 | 115.434 | 0 | 147.415 |
| Total Income - EUR | 0 | 34.656 | 42.328 | 53.794 | 67.472 | 78.788 | 105.670 | 115.439 | 0 | 147.425 |
| Total Expenses - EUR | 99 | 10.545 | 11.424 | 20.950 | 32.198 | 45.706 | 44.198 | 58.779 | 0 | 75.130 |
| Gross Profit/Loss - EUR | -99 | 24.111 | 30.904 | 32.844 | 35.274 | 33.082 | 61.472 | 56.660 | 0 | 72.294 |
| Net Profit/Loss - EUR | -99 | 23.364 | 29.159 | 32.306 | 34.600 | 32.378 | 60.501 | 55.780 | 0 | 67.960 |
| Employees | 0 | 1 | 1 | 2 | 2 | 2 | 3 | 3 | 0 | 3 |
Check the financial reports for the company - Norana Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 854 | 17.086 | 40.504 | 35.474 | 29.124 | 0 | 37.444 |
| Current Assets | 171 | 43.150 | 68.487 | 96.748 | 117.804 | 115.621 | 55.346 | 54.727 | 0 | 39.523 |
| Inventories | 0 | 23 | 0 | 13 | 0 | 1.404 | 0 | 0 | 0 | 1.274 |
| Receivables | 0 | 3.577 | 4.032 | 5.568 | 8.033 | 639 | 13.411 | 31.313 | 0 | 1.377 |
| Cash | 171 | 39.550 | 64.455 | 91.167 | 109.771 | 113.578 | 41.935 | 23.414 | 0 | 36.872 |
| Shareholders Funds | -54 | 23.310 | 52.075 | 83.425 | 116.410 | 146.580 | 52.217 | 77.742 | 0 | 75.481 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 0 | 40 |
| Debts | 225 | 19.840 | 16.412 | 14.176 | 18.481 | 9.545 | 38.603 | 6.109 | 0 | 1.485 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Norana Med S.r.l.